pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
nivolumab biosimilar
Bladder Cancer
Xbrane Biopharma AB
Marketed
nizatidine
Nizatidine
Acid Indigestion (Heartburn/Pyrosis)
Epic Pharma LLC
Phase 3
nizubaglustat
nizubaglustat [INN]
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Azafaros BV
Phase 3
← prev
page 200 of 231
next →
Pain
89
Neurology
1
nofazinlimab
nofazinlimab [INN]
Hepatocellular Carcinoma
CStone Pharmaceuticals Co Ltd
pre_registration
nogapendekin alfa
Anktiva (nogapendekin alfa)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
$IBRX
ImmunityBio, Inc.
Phase 2
nomlabofusp
nomlabofusp
Friedreich Ataxia
$LRMR
Larimar Therapeutics, Inc.
Phase 3
norelgestromin
norelgestromin
Female Contraception
$VTRS
Viatris Inc
Marketed
norethindrone
Norethindrone
Female Contraception
Naari USA Inc
Marketed
norgestrel
Opill (norgestrel)
Female Contraception
HRA Pharma LLC
Phase 1
norovirus [strain GI.1] vaccine
Norovirus Infections
$VXRT
Vaxart, Inc.
Marketed
north american coral snake [Micrurus fulvius] antivenom [equine]
Antivenin (Micrurus fulvius)
Poisoning
$PFE
PFIZER INC
Marketed
nortriptyline hydrochloride
Nortriptyline Hydrochloride
Depression
PAI Holding Co LLC
Phase 3
nucresiran
nucresiran [INN]
Familial Amyloid Cardiomyopathy
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
Phase 2
nulabeglogene autogedtemcel
nulabeglogene autogedtemcel
Sickle Cell Disease
Kamau Therapeutics Inc
Marketed
nusinersen
Spinraza (nusinersen)
Spinal Muscular Atrophy (SMA)
$BIIB
BIOGEN INC.
Phase 2
nuvisertib hydrochloride
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
Marketed
nystatin
Nystatin (nystatin [INN])
Chronic Mucocutaneous Candidiasis
Actavis Mid Atlantic LLC
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$AUTL
Autolus Therapeutics plc
Phase 3
obefazimod
obefazimod
Ulcerative Colitis
Abivax SA
Phase 1
oberotatug ravtansine
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
Phase 3
obexelimab
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
$ZBIO
Zenas BioPharma, Inc.
Phase 3
obicetrapib calcium
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
Marketed
obiltoxaximab
Anthim (obiltoxaximab)
Anthrax
Elusys Therapeutics Inc
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
Phase 3
obudanersen sodium
obudanersen sodium
Angelman Syndrome
$IONS
IONIS PHARMACEUTICALS INC
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
Marketed
ocrelizumab
Ocrevus (ocrelizumab)
Primary Progressive Multiple Sclerosis (PPMS)
Genentech Inc
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
pre_registration
octreotide LA
Oclaiz (octreotide)
Acromegaly
Camurus AB
